Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no changes to study details, eligibility criteria, outcomes, or safety information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.1. No substantive changes to the study details, eligibility criteria, or outcomes are evident.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved the government funding lapse notice banner from the page, removing an operational alert without altering trial data or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page content and layout appear unchanged between screenshots, with no additions or removals affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedUpdated core results content and data-sharing details have been added (new survival metrics, definitions, IPD sharing plans, and contact information), while older result-status language and some outdated items were removed.SummaryDifference16%

- Check76 days agoChange DetectedMajor updates include a government funding status notice and an OS update to v3.2.0; the previous v3.1.0 tag was removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.